A solid pharmaceutical dosage form [19] has micro- or nanostructures [10a, 10b,10c, 1Od] impressed on the surface thereof or an interface thereof. The dosageform [19] includes a suitable quantity and distribution of ingredients, suchas one or more dyes, so as to enhance the optical contrast effect, C, caused by themicro- or nanostructures so that the micro- or nanostructures are observableby the human eye and thereby able to provide anti- counterfeiting characteristicsto the dosage form.